Yesterday was the worst day of the year for cannabis stocks, with HEXO (no longer in our portfolio) leading the way down with a plunge of 22.5% after the company announced that revenue for the fiscal fourth quarter, ended July, would be $14.5 $16.5...
Read More
During any market drop, you might ask, "Should I sell my stocks?" Here are a few guidelines on when to sell stocks and when to hold them.
Read More
The cannabis sector has been trending down since the end of March, giving back its spectacular gains from the start of the year, and until now I’ve remained optimistic about our stocks, partially because of their outstanding fundamental growth metrics but also because two...
Read More
The shares of our first idea today were just initiated with a ‘Buy’ rating at Jefferies. Our second recommendation is a sale of a company whose guidance has faltered.
Read More
In the broad market, all is well, as all trend-following indicators are positive, and the number of stocks hitting new lows has been minuscule in recent days.
Read More
One major factor in investing, particularly in small stocks and young sectors where growing pains are still the norm, is sentiment. Good sentiment can take a sector to extreme highs—as it has done for the marijuana sector at every major legalization milepost.
Read More
Cloud software stocks are on a tear, and these three have particularly good-looking charts. Any one of them would be worth a flier.
Read More
If you know how to find small-cap stocks, you can consistently unlock better-than-average market returns. These five steps will help you find the right small caps.
Read More
As summer morphs into fall and Wall Street returns to full operation, I’m seeing some welcome signs of buying in the cannabis sector. So today we’ll join them, by averaging up in two of our holdings.
Read More
Contrary to all the doom and gloom, the U.S. economy is doing just fine, thanks. And Ally Financial stock is a perfect way to play its growth.
Read More
If you want to spread out your dividend payments, an ex-dividend date calendar is a handy way to keep track of all your payments. Here's how it works.
Read More
Yesterday’s strong market triggered a technical indicator, a follow-through signal that tells us buyers are lurking. Of course, today’s big decline so far isn’t good to see, but nevertheless, this and other measures (awful sentiment, etc.) tell us there should be support on weakness.
Read More
The good news is that many cannabis companies have been releasing their second quarter reports and the results have been excellent.
Read More
The cannabis sector is still in correction mode ... looking for a bottom somewhere.
Read More
As with Chinese stocks a decade and a half ago, the government is making it easier for marijuana investing. And that means you should start buying now.
Read More
When you invest with conviction, you can rest easy knowing that your investment portfolio is comprised solely of companies you truly believe in.
Read More
New data from an Apple Heart Study could be a boon for these two small-cap MedTech stocks - assuming the Apple Watch does what it's supposed to do.
Read More
The market has bounced back, and there are a number of growth stocks hitting new highs. Here are five with the best charts.
Read More
Halloween in Salem is a unique experience, and I fully embraced the fun of it long ago. And that's the same kind of attitude you need to have in investing.
Read More
Eleven years ago, Sears stock was at all-time highs, a $23 billion company. Now the company is bankrupt, and the stock is almost at zero. What happened?!
Read More
